|
Fusion Gene Summary | |
Fusion Gene ORF analysis | |
Fusion Genomic Features | |
Fusion Protein Features | |
Fusion Gene Sequence | |
Fusion Gene PPI analysis | |
Related Drugs | |
Related Diseases |
Fusion gene:CLEC3A-SPTLC2 (FusionGDB2 ID:HG10143TG9517) |
Fusion Gene Summary for CLEC3A-SPTLC2 |
Fusion gene summary |
Fusion gene information | Fusion gene name: CLEC3A-SPTLC2 | Fusion gene ID: hg10143tg9517 | Hgene | Tgene | Gene symbol | CLEC3A | SPTLC2 | Gene ID | 10143 | 9517 |
Gene name | C-type lectin domain family 3 member A | serine palmitoyltransferase long chain base subunit 2 | |
Synonyms | CLECSF1 | HSN1C|LCB2|LCB2A|NSAN1C|SPT2|hLCB2a | |
Cytomap | ('CLEC3A')('SPTLC2') 16q23.1 | 14q24.3 | |
Type of gene | protein-coding | protein-coding | |
Description | C-type lectin domain family 3 member AC-type (calcium dependent, carbohydrate-recognition domain) lectin, superfamily member 1 (cartilage-derived) | serine palmitoyltransferase 2LCB 2SPT 2long chain base biosynthesis protein 2aserine palmitoyltransferase, subunit IIserine-palmitoyl-CoA transferase 2 | |
Modification date | 20200313 | 20200313 | |
UniProtAcc | . | . | |
Ensembl transtripts involved in fusion gene | ENST00000299642, ENST00000575655, ENST00000565808, | ||
Fusion gene scores | * DoF score | 1 X 1 X 1=1 | 6 X 6 X 3=108 |
# samples | 1 | 6 | |
** MAII score | log2(1/1*10)=3.32192809488736 | log2(6/108*10)=-0.84799690655495 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
Context | PubMed: CLEC3A [Title/Abstract] AND SPTLC2 [Title/Abstract] AND fusion [Title/Abstract] | ||
Most frequent breakpoint | CLEC3A(78056638)-SPTLC2(77987924), # samples:1 | ||
Anticipated loss of major functional domain due to fusion event. | CLEC3A-SPTLC2 seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF. CLEC3A-SPTLC2 seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF. |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
Partner | Gene | GO ID | GO term | PubMed ID |
Tgene | SPTLC2 | GO:0030148 | sphingolipid biosynthetic process | 25332431|26573920 |
Tgene | SPTLC2 | GO:0046513 | ceramide biosynthetic process | 25691431 |
Tgene | SPTLC2 | GO:1904504 | positive regulation of lipophagy | 25332431 |
Fusion gene breakpoints across CLEC3A (5'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
Fusion gene breakpoints across SPTLC2 (3'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
Fusion gene information * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Source | Disease | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
ChimerDB4 | BRCA | TCGA-A2-A0YI-01A | CLEC3A | chr16 | 78056638 | + | SPTLC2 | chr14 | 77987924 | - |
Top |
Fusion Gene ORF analysis for CLEC3A-SPTLC2 |
Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
5CDS-intron | ENST00000299642 | ENST00000556264 | CLEC3A | chr16 | 78056638 | + | SPTLC2 | chr14 | 77987924 | - |
5CDS-intron | ENST00000575655 | ENST00000556264 | CLEC3A | chr16 | 78056638 | + | SPTLC2 | chr14 | 77987924 | - |
In-frame | ENST00000299642 | ENST00000216484 | CLEC3A | chr16 | 78056638 | + | SPTLC2 | chr14 | 77987924 | - |
In-frame | ENST00000575655 | ENST00000216484 | CLEC3A | chr16 | 78056638 | + | SPTLC2 | chr14 | 77987924 | - |
intron-3CDS | ENST00000565808 | ENST00000216484 | CLEC3A | chr16 | 78056638 | + | SPTLC2 | chr14 | 77987924 | - |
intron-intron | ENST00000565808 | ENST00000556264 | CLEC3A | chr16 | 78056638 | + | SPTLC2 | chr14 | 77987924 | - |
ORFfinder result based on the fusion transcript sequence of in-frame fusion genes. |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | Seq length (transcript) | BP loci (transcript) | Predicted start (transcript) | Predicted stop (transcript) | Seq length (amino acids) |
ENST00000299642 | CLEC3A | chr16 | 78056638 | + | ENST00000216484 | SPTLC2 | chr14 | 77987924 | - | 6900 | 227 | 85 | 612 | 175 |
ENST00000575655 | CLEC3A | chr16 | 78056638 | + | ENST00000216484 | SPTLC2 | chr14 | 77987924 | - | 6869 | 196 | 54 | 581 | 175 |
DeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated. |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | No-coding score | Coding score |
ENST00000299642 | ENST00000216484 | CLEC3A | chr16 | 78056638 | + | SPTLC2 | chr14 | 77987924 | - | 0.004310441 | 0.9956896 |
ENST00000575655 | ENST00000216484 | CLEC3A | chr16 | 78056638 | + | SPTLC2 | chr14 | 77987924 | - | 0.004251231 | 0.9957488 |
Top |
Fusion Genomic Features for CLEC3A-SPTLC2 |
FusionAI prediction of the potential fusion gene breakpoint based on the pre-mature RNA sequence context (+/- 5kb of individual partner genes, total 20kb length sequence). FusionAI is a fusion gene breakpoint classifier based on convolutional neural network by comparing the fusion positive and negative sequence context of ~ 20K fusion gene data. From here, we can have the relative potentency of the 20K genomic sequence how individual sequnce will be likely used as the gene fusion breakpoints. |
Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | 1-p | p (fusion gene breakpoint) |
Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions. We integrated a total of 44 different types of human genomic feature loci information across five big categories including virus integration sites, repeats, structural variants, chromatin states, and gene expression regulation. More details are in help page. |
Top |
Fusion Protein Features for CLEC3A-SPTLC2 |
Four levels of functional features of fusion genes Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/chr16:78056638/chr14:77987924) - FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels. - How to search 1. Put your fusion gene symbol. 2. Press the tab key until there will be shown the breakpoint information filled. 4. Go down and press 'Search' tab twice. 4. Go down to have the hyperlink of the search result. 5. Click the hyperlink. 6. See the FGviewer result for your fusion gene. |
Main function of each fusion partner protein. (from UniProt) |
Hgene | Tgene |
. | . |
FUNCTION: Transcriptional activator which is required for calcium-dependent dendritic growth and branching in cortical neurons. Recruits CREB-binding protein (CREBBP) to nuclear bodies. Component of the CREST-BRG1 complex, a multiprotein complex that regulates promoter activation by orchestrating a calcium-dependent release of a repressor complex and a recruitment of an activator complex. In resting neurons, transcription of the c-FOS promoter is inhibited by BRG1-dependent recruitment of a phospho-RB1-HDAC1 repressor complex. Upon calcium influx, RB1 is dephosphorylated by calcineurin, which leads to release of the repressor complex. At the same time, there is increased recruitment of CREBBP to the promoter by a CREST-dependent mechanism, which leads to transcriptional activation. The CREST-BRG1 complex also binds to the NR2B promoter, and activity-dependent induction of NR2B expression involves a release of HDAC1 and recruitment of CREBBP (By similarity). {ECO:0000250}. | FUNCTION: Transcriptional activator which is required for calcium-dependent dendritic growth and branching in cortical neurons. Recruits CREB-binding protein (CREBBP) to nuclear bodies. Component of the CREST-BRG1 complex, a multiprotein complex that regulates promoter activation by orchestrating a calcium-dependent release of a repressor complex and a recruitment of an activator complex. In resting neurons, transcription of the c-FOS promoter is inhibited by BRG1-dependent recruitment of a phospho-RB1-HDAC1 repressor complex. Upon calcium influx, RB1 is dephosphorylated by calcineurin, which leads to release of the repressor complex. At the same time, there is increased recruitment of CREBBP to the promoter by a CREST-dependent mechanism, which leads to transcriptional activation. The CREST-BRG1 complex also binds to the NR2B promoter, and activity-dependent induction of NR2B expression involves a release of HDAC1 and recruitment of CREBBP (By similarity). {ECO:0000250}. |
Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at * Minus value of BPloci means that the break pointn is located before the CDS. |
- In-frame and retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
- In-frame and not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Hgene | CLEC3A | chr16:78056638 | chr14:77987924 | ENST00000575655 | + | 1 | 3 | 74_192 | 38 | 198.0 | Domain | C-type lectin |
Tgene | SPTLC2 | chr16:78056638 | chr14:77987924 | ENST00000216484 | 8 | 12 | 67_87 | 434 | 563.0 | Transmembrane | Helical |
Top |
Fusion Gene Sequence for CLEC3A-SPTLC2 |
For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. To have fusion amino acid sequence, we ran ORFfinder and chose the longest ORF among the all predicted ones. |
>17096_17096_1_CLEC3A-SPTLC2_CLEC3A_chr16_78056638_ENST00000299642_SPTLC2_chr14_77987924_ENST00000216484_length(transcript)=6900nt_BP=227nt ACTTTTATAAGCCAGCCCCAGGCATCCCAGAGCAAGATGTAGCTGTGTAGTCTCCTTCCATAGCTGCTCTAAGGGGGCTGGCAACATGGC TCAGCAGGCTTGCCCCAGAGCCATGGCAAAGAATGGACTTGTAATTTGCATCCTGGTGATCACCTTACTCCTGGACCAGACCACCAGCCA CACATCCAGATTAAAAGCCAGGAAGCACAGCAAACGTCGAGTGAGAGGTAAAGAGTGTGTACAACAGTTAGCTGAAAACACCAGGTATTT CAGGAGACGCCTGAAAGAGATGGGCTTCATCATCTATGGAAATGAAGACTCTCCAGTAGTGCCTTTGATGCTCTACATGCCTGCCAAAAT TGGCGCCTTTGGACGGGAGATGCTGAAGCGGAACATCGGTGTCGTTGTGGTTGGATTTCCTGCCACCCCAATTATTGAGTCCAGAGCCAG GTTTTGCCTGTCAGCAGCTCATACCAAAGAAATACTTGATACTGCTTTAAAGGAGATAGATGAAGTTGGGGACCTATTGCAGCTGAAGTA TTCCCGTCATCGGTTGGTACCTCTACTGGACAGGCCCTTTGACGAGACGACGTATGAAGAAACAGAAGACTGAGCCTTTTTGGTGCTCCC TCAGAGGAACTCTCCCTCACCCAGGACAGCCTGTGGCCTTTGTGAGCCAGTTCCAGGAACCACACTTCTGTGGCCATCTCACGTGAAAGA CATTGCCTCAGCTACTGAAGGTGGCCACCTCCACTCTAAATGACATTTTGTAAATAGTAAAAAACTGCTTCTAATCCTTCCTTTGCTAAA TCTCACCTTTAAAAACGAAGGTGACTCACTTTGCTTTTTCAGTCCATTAAAAAAACATTTTATTTTGCAACCATTCTACTTGTGAAATCA CGCTGACCCTAGCCTGTCTCTGGCTAACCACACAGGCCATTCCCCTCTCCCAGCACCTTGCAGACTTGGGCCCATCAAGAGCTACTGCTG GCCCTGGCTCCGCAGCCTGGATACTTACCTGGCCCTCCTCCCTAGGGAGCAAGTGCCTTCCACTTACTTCCCATCCAGGTCTCAGAGGTC TCAAGGCCAACCTTGGAATCCTTATTTAACCATTCAAGTAATCAACGGAAGTTTTCACCCTTTAATCTTAAGTTTAGCCTTTTAAGAAAA ACAGTAAGCGATGACTGCTGAAAGGCTCATTGTGTAATCTCCCAAGGGTTTGGTCTTATTCCATTTTCTTCTGGTCACCAGATGATTTCT TCCTTTACCATCAAATACTTCTTCATAATGGTCACAGTCTGAGGATGTGCGCAAATTCTGGTTCTTCCCAAGCTCTAACCGTAACACGTC CCACCCCCTTTTTAAAGCACTTACTGTTTTCAGAGCACCCATATCCCACCCTGGTGAGAAGGCCACTCTCACATCTGAGTGTTGGGTACA AAGCTGCTCCGTAGAGTGATGTGCACTCCTGGTGGGTGAGGGGCAGGGGCAGTGGCAGTGTGCAAAGAATTGATTACTCCTTGCAGAGCC TGTGGCTTGCATTTCCTACTGCTTTCTACGTTTGAAAATTATGACAGTCTCTGGCTAGGTCTGGGTCCAGATTAGGATTTAAACTGATAA AGGAAACTGTTGGTAAATCCTCTGCTCAGAAAGCATTTATCATGTTCCTATTTAAGGATTAGGTTTATTAATTTAGGCCTCTTAGAAGCT AACCCACTTAAATATTACTCTTCTGAATGCTAGTTCTCTTTTATTCTTGATGTCCTAAGTCAATTGAATCTGGCATCTGGGGCTAGGGTC TGCCTGTCTACATATTTTTTATTTTTTTCTGAGAAATTCTGAACACATAGATCTCTTTCCTAAACTGACATTTTCTATTTTGACTGTTTT CATACTATAACCAGGTAAAGGGACTTCTTTCAGAGAGCTTTATACTGCCTGACCAAAGAACAAATCTGAAAATCACCATTTTAAAGTTAT TTTTTCAGTTGAACCAAAGTTTAAGTGAAGAGGACTTTTGGCATATTATACCCAGGATCAGTTTGTCTTTTTGTATCCATCAAGTATTAC AGGAGAAGGATTGGGAACAGAATGGAAAAACAGTGTATGAAAGTCATGTTACAGGCCGAGTGCGGTGGCTCACACCTGTAATCCTAGCAC TTTGGGAGGCTGAGGCAGGTGGCTCACTTGAGGTCAGGAATTCAAGACCAGCCTGGCCAACATGGTGAAACCCCGTCTCTACTAAAAAGA CAAAAAATTAGCTGGGCGTGGTGGCGGGCACCTATAATCCCACCTACTTGGTAGGCTGAGGCAGGAGAATCGCTTGAACCCAGGAGGCGG AGGTTGCAGTGAGACGAGATTGTGCCACTGCACTCTAGCCTGGGTGACAGAGCAAAACTGTGTCTCAAAAAAAAAAGTCATGTTACACAT TTAAGTTTTTGAAATTGCTCCTTTTATCGGTAAAGATTCTCAATCCAAATTCTCCTGGGTGTGTTGTCATCAGCTGTGATATGTTTGTGC ACATTACGTATAGCAGAGGATGTAAGCAATATTATTGTTTGTGAAGTTTTGTTTTTAATGTCTTGAGTATGAGTTATGTTTAGTCACTGT CAGCATCTGAGAACTTTAATAAGCCCTTGAGATATTCCAAAGTTTTATTTTACTTTTTTAAAGAACAGAAAAAGATGAATGAAAGAACCA AGGAGAGATGCAGAGACTATATTTAGCATGTATAGGTTAAAGTAAGAAGGAGGTTGTGGTAACTAAATAGGAGTCCTATAAAATCAAATA CATTGTCAACCTTTTCTGCACATCTAGTTTCCTACCATAGAATCCCACTGGAATACCACATAGCTTTTGCACTGCAGTTACTATTTACTA ATGTAAACGTAGGGTTTGTAAAAGTCACAAACTTATAAGCAATGAACTTACCTGCTAGTCTTTTTATTTTGGCTTGCATGAAGTCACTGC AAATTCAAATGTCAGTACCGGCATTTAAAATATATCTATATCACTTTGTTGGTACAAAGTTATTTCAAGATAAGTGTAATTTTGTTACAA GTTTATTTTGAAGAGACAAATCTCCTGTGATCTATGCAGGACCTCTGTACTTTCTAAAGAACAAAATGTTATGTAGACATTATACATGGT TGGTTGTCTCTTCTTGAAACTGTAATGTAAATCTAGGGTCCAGTCATATCCTAGGTATCATCATTTATCCAAGTACTTGGAGGAATACAA GTATATATAAATACAGTCATTGAGAATAAGTCGATTTGAGGCATACAAGAGTAGTTTCTTACACAGTTTAACACGGCCTGATTCAAGACT CTGATAGGATTCAAACAGATACCGGTTAACCATGACTACCAAAACTGATCATCTGAGTCGATTGATAGAGGTGTGACTAGTCCTTAGCAC TTTTTCTCATTCCTCTTTTTATTCAGCATTGCTGTTACCTATTTCAGGTTTATAAGACCTCTTTCAGCAGATCACATCAGAAGCCAGGAA ATGCATAGCTAGGAGATGTCAAAAGCCCATATGAGGAGTGGACCAAGCAGCAGTGGCGGTTTCTCCTCGCATCTTTTTTTTTTTAAGCTT TAACTTAGCAGGGGCATGGACTTTATAGCACTTTTTCAACTTTTTGCTTTGCTTTGGATAAGAAATCCTTACCTTTAAAAAAAGCTTCTA GTCTCCATAACCCCCAAAGTACTGCTTATTTGTTTGAAGAATCCAGCCATCGTAGTGCTTTAGTCACTATCGTAAACATTCATGATAGGG CAAGGATTTTAAAACAGGATTCTTGCTTCTGTAGTCATCAAGGTGAACAGAAGCATCCTACACAACCACTAAGGGCTCTATGTTTGTGTC ATGCCTCTTCAAACACCAAGGAGTTGAACATGCTTCCAGTGATTTGTCTCCGTAATGCCTTCTTCCTTTATTTGGCCTTTCTTTCTTTCT GTACCTTCAAGTTCTTGATTTTTAAAATTCCAACTCTAGAGAAAACCAATATATGGTGGTGCTGGGCTTTGAAGATAGCATATCAGACGC CTTGGTTCTGTTTGTACACTTAGCCTTACATTTCAGGAGGAGGCTTTTCATTAGGGGCTTAAGCTAGCTCCTTTGGCTTTTAAAAAAAAT TTTTTTTCAAATTTCTTCATTACCTAAGGGAGCCTGCATCTAAATTTCTCAACTAGTTCAGCCTAGCTGAATTTTCTAGTGTGTTATACA CTTTGCTTCCTTCTTATTGGTGAAAACCAGGGGGATGAGTGGCTTCCATGGAGAGATTTCCTGATTTCTCAGGGAGGAAAAAAGTGATGA CATTTACCACTACTTTTATGTTTTTCCCCTTTTTCCAAATTGATAAGGATTTCTGGTTCCTAGTGATCCGGGATTGGGCAACAGTGCAGA ACTGCCAGTCATGCCGTAGGCCGTGAAGAAAGAATGTGAGTAACTGTTGTTTTGCAAGGATTTGTAGGGTTATGGGCAGTTGTTGTTTGA AGCATTGCTATGACCTAATTCCCAAGGTATCTTTCCTCTCTTGGTGTTCTAGGTAAGCCAATGAGCTTTAATCTCTACTTGCTATAACCG TGTGCTTAGAAAAAGAGGTGAGAGTAGTGGTTTTCCTTCAAACTGTCCACATTCATGAAGATTATGAATTGTTAGGACAGCCAGGGCAAG ATAGACCCTGTCTCTACAAAAATTTTTTTCTAAATTAACCGGGCATGGTGGTGCCTGCCTGTAGTCCCACCTGTGTGGGAGAATCACTTG AGCCTGGGAGGTCAAGGCTGCAGTGAGCCATGATTGCACCCCTGCACTCCAGCCTGGGTGACAGAGTGAGACCCTGGCTCAATAAGAGGG GGAAAAAAAATTGTTAGGAGCTGGGTGCGGATGCAGCCTGCAATCCCAGCTACTTGAGAGGCTGAGGCCGGAGGATTGCTTAAACCCAAG AATTTGAGCGTAGCCTGGGCAACACAGCAAGACCCCATCTAAGAAAAAAATGTTTTTTAAATCAGCTTAGCCCAAAGGGGTTGTGAATGG GGAGGTATAAAAAGCAAAGATTATTTTTTGGCTACTAAGCCAAGAACTTACAGGGATTTTTTTTTTCAGTCCCAGAACCTACAGATACCC TGCTACTTGCTTCACGTGGATGCTCAGTGCCCAGCAGCCATCTTAATACATTAAACCAGTTTAAAAAATACCTTCCATGTGGAGAAAAAC ATGTCTTTTTCTCGCCTCAACTTTATCCACATGAAATATGTGCCCATGGCTGGGCGCAGTGGCTCACCTGTAATCCCAACACTTTGGGAG GCTGAAGCAGGCAGATTGCTTGAGGCCAGGAGTTCGAGAACAGTCTGGCCAACATGGCGAAACCTCATCTCTACTAAAATTACAAAAATT AGCCGGGCATGGTGGCACATGCCTGTAATCCCAGCTACGTCAGGAGGCTGAGGCACAGGAATTGCTTGAACCCAAGAGGCAGAGGATGCA ATGAGCCAAGATCACACCACTGCACTCCAGCCTTGGCGACAGAGGGAGACTCTGTCTCAAAAAAAAAAAAAAAAGGTGTGCCCAGGCCCC TAGCCATTGCCATGTGCCCAGCCAGAGAGCCAAATTAGAGGGCTGGCTTCCCTATCACACAGAATAAATGCTAGTGCTAGCCAATGATCC CTTTGCTTTTAATGTATAGAAAATACTGTTGTTCCTTTTGTCATTTCCAGTGACATCTGTTTTCTAAGCAGCTCTTTTCTAGGGAGGAAA CCAAAGGGGCTAGGTTAAGACCCTAATAGAAATGTTTTTTCTAATCTCTGGTGAGTCTGGAAGTGTCACATTCACAGTCCACCCTTGGGA GTGGCTTGGTGGAGCTGGGGACAAGGTTTTGTTTACTACATAGTGCACATGATAAATGGCCTTAAACTGTGATTCTTTCTGGTAGGATAA GTTATAATAAACTGACCCTAAAGAATGCAATGGCTTTTAAACTGCAGTTACTGTGTTCTTAATGAAGCAATACCCAAAGCTCTGTTCTTT TGGAGCACTTGAGGGGAGCTTGAATGAAAGGTGCAGATAAGAGCAGTACCTTGATCTTATGCTTTCTGAGTGTCCTGCCTTGTTGCCATC TGCATGGATGAGTGAATGCTTCTATGCACGAGGAGACTCAAGCCAACTCAGAGTCTGCTTTTTCCAACGCTCTTCCCAGGTTTCTTTTGC AAAGCTTGGTCATTTGGCCCAGGTCTTCCTGGAAAGTGGAGTACATGTCACTGACTAGGGTGGCGTGGTGTCTTTACCCTTAACATTAAG TCTTGTTACCTCAGTGATGTGAAGCCAATGGTTGGAATTATAAAAAGCATCCTTGCTGGTTCTTCACAGGACACTGGAACCCACCCTGTC AATTCAGCTAGCATGTCCACACAGTCTTGATGATCCCTCTCTGTAACAGGCAGCTAACATTAAGAGAAGGGGGAAAGAGAAGAAGAGAGC AATAGCTTATGGGAGAGCTGAGATCTTACTTCGTTGACCCATATTTTTCCCCTGACCAAGTTACCTGTAAACTGGAATTTGCAAGGGGAT GCTGTGATGATAACCCCTTTCTATTGCTGTAATGTTCATATAACCTGGGAAACTGAGAGAAGGGGATGTGTAAATAAAAGCTTAAACATT TTAGTAATGTGTTAAAATGTCACTCTCTCTTACCCTGTTTCCCTTTTTTGCCAGATGATGATTTTTTTATTTTTATTTTGTACTTTACTG GATGACTGTGAAGCGATGAGTATTGGGTTGGGGTAGGTGTGTTGATTTTGAGAGTGCATGTTAAGAACTGAAGGGGAACTACTTGAGATG >17096_17096_1_CLEC3A-SPTLC2_CLEC3A_chr16_78056638_ENST00000299642_SPTLC2_chr14_77987924_ENST00000216484_length(amino acids)=175AA_BP=47 MAQQACPRAMAKNGLVICILVITLLLDQTTSHTSRLKARKHSKRRVRGKECVQQLAENTRYFRRRLKEMGFIIYGNEDSPVVPLMLYMPA -------------------------------------------------------------- >17096_17096_2_CLEC3A-SPTLC2_CLEC3A_chr16_78056638_ENST00000575655_SPTLC2_chr14_77987924_ENST00000216484_length(transcript)=6869nt_BP=196nt GCAAGATGTAGCTGTGTAGTCTCCTTCCATAGCTGCTCTAAGGGGGCTGGCAACATGGCTCAGCAGGCTTGCCCCAGAGCCATGGCAAAG AATGGACTTGTAATTTGCATCCTGGTGATCACCTTACTCCTGGACCAGACCACCAGCCACACATCCAGATTAAAAGCCAGGAAGCACAGC AAACGTCGAGTGAGAGGTAAAGAGTGTGTACAACAGTTAGCTGAAAACACCAGGTATTTCAGGAGACGCCTGAAAGAGATGGGCTTCATC ATCTATGGAAATGAAGACTCTCCAGTAGTGCCTTTGATGCTCTACATGCCTGCCAAAATTGGCGCCTTTGGACGGGAGATGCTGAAGCGG AACATCGGTGTCGTTGTGGTTGGATTTCCTGCCACCCCAATTATTGAGTCCAGAGCCAGGTTTTGCCTGTCAGCAGCTCATACCAAAGAA ATACTTGATACTGCTTTAAAGGAGATAGATGAAGTTGGGGACCTATTGCAGCTGAAGTATTCCCGTCATCGGTTGGTACCTCTACTGGAC AGGCCCTTTGACGAGACGACGTATGAAGAAACAGAAGACTGAGCCTTTTTGGTGCTCCCTCAGAGGAACTCTCCCTCACCCAGGACAGCC TGTGGCCTTTGTGAGCCAGTTCCAGGAACCACACTTCTGTGGCCATCTCACGTGAAAGACATTGCCTCAGCTACTGAAGGTGGCCACCTC CACTCTAAATGACATTTTGTAAATAGTAAAAAACTGCTTCTAATCCTTCCTTTGCTAAATCTCACCTTTAAAAACGAAGGTGACTCACTT TGCTTTTTCAGTCCATTAAAAAAACATTTTATTTTGCAACCATTCTACTTGTGAAATCACGCTGACCCTAGCCTGTCTCTGGCTAACCAC ACAGGCCATTCCCCTCTCCCAGCACCTTGCAGACTTGGGCCCATCAAGAGCTACTGCTGGCCCTGGCTCCGCAGCCTGGATACTTACCTG GCCCTCCTCCCTAGGGAGCAAGTGCCTTCCACTTACTTCCCATCCAGGTCTCAGAGGTCTCAAGGCCAACCTTGGAATCCTTATTTAACC ATTCAAGTAATCAACGGAAGTTTTCACCCTTTAATCTTAAGTTTAGCCTTTTAAGAAAAACAGTAAGCGATGACTGCTGAAAGGCTCATT GTGTAATCTCCCAAGGGTTTGGTCTTATTCCATTTTCTTCTGGTCACCAGATGATTTCTTCCTTTACCATCAAATACTTCTTCATAATGG TCACAGTCTGAGGATGTGCGCAAATTCTGGTTCTTCCCAAGCTCTAACCGTAACACGTCCCACCCCCTTTTTAAAGCACTTACTGTTTTC AGAGCACCCATATCCCACCCTGGTGAGAAGGCCACTCTCACATCTGAGTGTTGGGTACAAAGCTGCTCCGTAGAGTGATGTGCACTCCTG GTGGGTGAGGGGCAGGGGCAGTGGCAGTGTGCAAAGAATTGATTACTCCTTGCAGAGCCTGTGGCTTGCATTTCCTACTGCTTTCTACGT TTGAAAATTATGACAGTCTCTGGCTAGGTCTGGGTCCAGATTAGGATTTAAACTGATAAAGGAAACTGTTGGTAAATCCTCTGCTCAGAA AGCATTTATCATGTTCCTATTTAAGGATTAGGTTTATTAATTTAGGCCTCTTAGAAGCTAACCCACTTAAATATTACTCTTCTGAATGCT AGTTCTCTTTTATTCTTGATGTCCTAAGTCAATTGAATCTGGCATCTGGGGCTAGGGTCTGCCTGTCTACATATTTTTTATTTTTTTCTG AGAAATTCTGAACACATAGATCTCTTTCCTAAACTGACATTTTCTATTTTGACTGTTTTCATACTATAACCAGGTAAAGGGACTTCTTTC AGAGAGCTTTATACTGCCTGACCAAAGAACAAATCTGAAAATCACCATTTTAAAGTTATTTTTTCAGTTGAACCAAAGTTTAAGTGAAGA GGACTTTTGGCATATTATACCCAGGATCAGTTTGTCTTTTTGTATCCATCAAGTATTACAGGAGAAGGATTGGGAACAGAATGGAAAAAC AGTGTATGAAAGTCATGTTACAGGCCGAGTGCGGTGGCTCACACCTGTAATCCTAGCACTTTGGGAGGCTGAGGCAGGTGGCTCACTTGA GGTCAGGAATTCAAGACCAGCCTGGCCAACATGGTGAAACCCCGTCTCTACTAAAAAGACAAAAAATTAGCTGGGCGTGGTGGCGGGCAC CTATAATCCCACCTACTTGGTAGGCTGAGGCAGGAGAATCGCTTGAACCCAGGAGGCGGAGGTTGCAGTGAGACGAGATTGTGCCACTGC ACTCTAGCCTGGGTGACAGAGCAAAACTGTGTCTCAAAAAAAAAAGTCATGTTACACATTTAAGTTTTTGAAATTGCTCCTTTTATCGGT AAAGATTCTCAATCCAAATTCTCCTGGGTGTGTTGTCATCAGCTGTGATATGTTTGTGCACATTACGTATAGCAGAGGATGTAAGCAATA TTATTGTTTGTGAAGTTTTGTTTTTAATGTCTTGAGTATGAGTTATGTTTAGTCACTGTCAGCATCTGAGAACTTTAATAAGCCCTTGAG ATATTCCAAAGTTTTATTTTACTTTTTTAAAGAACAGAAAAAGATGAATGAAAGAACCAAGGAGAGATGCAGAGACTATATTTAGCATGT ATAGGTTAAAGTAAGAAGGAGGTTGTGGTAACTAAATAGGAGTCCTATAAAATCAAATACATTGTCAACCTTTTCTGCACATCTAGTTTC CTACCATAGAATCCCACTGGAATACCACATAGCTTTTGCACTGCAGTTACTATTTACTAATGTAAACGTAGGGTTTGTAAAAGTCACAAA CTTATAAGCAATGAACTTACCTGCTAGTCTTTTTATTTTGGCTTGCATGAAGTCACTGCAAATTCAAATGTCAGTACCGGCATTTAAAAT ATATCTATATCACTTTGTTGGTACAAAGTTATTTCAAGATAAGTGTAATTTTGTTACAAGTTTATTTTGAAGAGACAAATCTCCTGTGAT CTATGCAGGACCTCTGTACTTTCTAAAGAACAAAATGTTATGTAGACATTATACATGGTTGGTTGTCTCTTCTTGAAACTGTAATGTAAA TCTAGGGTCCAGTCATATCCTAGGTATCATCATTTATCCAAGTACTTGGAGGAATACAAGTATATATAAATACAGTCATTGAGAATAAGT CGATTTGAGGCATACAAGAGTAGTTTCTTACACAGTTTAACACGGCCTGATTCAAGACTCTGATAGGATTCAAACAGATACCGGTTAACC ATGACTACCAAAACTGATCATCTGAGTCGATTGATAGAGGTGTGACTAGTCCTTAGCACTTTTTCTCATTCCTCTTTTTATTCAGCATTG CTGTTACCTATTTCAGGTTTATAAGACCTCTTTCAGCAGATCACATCAGAAGCCAGGAAATGCATAGCTAGGAGATGTCAAAAGCCCATA TGAGGAGTGGACCAAGCAGCAGTGGCGGTTTCTCCTCGCATCTTTTTTTTTTTAAGCTTTAACTTAGCAGGGGCATGGACTTTATAGCAC TTTTTCAACTTTTTGCTTTGCTTTGGATAAGAAATCCTTACCTTTAAAAAAAGCTTCTAGTCTCCATAACCCCCAAAGTACTGCTTATTT GTTTGAAGAATCCAGCCATCGTAGTGCTTTAGTCACTATCGTAAACATTCATGATAGGGCAAGGATTTTAAAACAGGATTCTTGCTTCTG TAGTCATCAAGGTGAACAGAAGCATCCTACACAACCACTAAGGGCTCTATGTTTGTGTCATGCCTCTTCAAACACCAAGGAGTTGAACAT GCTTCCAGTGATTTGTCTCCGTAATGCCTTCTTCCTTTATTTGGCCTTTCTTTCTTTCTGTACCTTCAAGTTCTTGATTTTTAAAATTCC AACTCTAGAGAAAACCAATATATGGTGGTGCTGGGCTTTGAAGATAGCATATCAGACGCCTTGGTTCTGTTTGTACACTTAGCCTTACAT TTCAGGAGGAGGCTTTTCATTAGGGGCTTAAGCTAGCTCCTTTGGCTTTTAAAAAAAATTTTTTTTCAAATTTCTTCATTACCTAAGGGA GCCTGCATCTAAATTTCTCAACTAGTTCAGCCTAGCTGAATTTTCTAGTGTGTTATACACTTTGCTTCCTTCTTATTGGTGAAAACCAGG GGGATGAGTGGCTTCCATGGAGAGATTTCCTGATTTCTCAGGGAGGAAAAAAGTGATGACATTTACCACTACTTTTATGTTTTTCCCCTT TTTCCAAATTGATAAGGATTTCTGGTTCCTAGTGATCCGGGATTGGGCAACAGTGCAGAACTGCCAGTCATGCCGTAGGCCGTGAAGAAA GAATGTGAGTAACTGTTGTTTTGCAAGGATTTGTAGGGTTATGGGCAGTTGTTGTTTGAAGCATTGCTATGACCTAATTCCCAAGGTATC TTTCCTCTCTTGGTGTTCTAGGTAAGCCAATGAGCTTTAATCTCTACTTGCTATAACCGTGTGCTTAGAAAAAGAGGTGAGAGTAGTGGT TTTCCTTCAAACTGTCCACATTCATGAAGATTATGAATTGTTAGGACAGCCAGGGCAAGATAGACCCTGTCTCTACAAAAATTTTTTTCT AAATTAACCGGGCATGGTGGTGCCTGCCTGTAGTCCCACCTGTGTGGGAGAATCACTTGAGCCTGGGAGGTCAAGGCTGCAGTGAGCCAT GATTGCACCCCTGCACTCCAGCCTGGGTGACAGAGTGAGACCCTGGCTCAATAAGAGGGGGAAAAAAAATTGTTAGGAGCTGGGTGCGGA TGCAGCCTGCAATCCCAGCTACTTGAGAGGCTGAGGCCGGAGGATTGCTTAAACCCAAGAATTTGAGCGTAGCCTGGGCAACACAGCAAG ACCCCATCTAAGAAAAAAATGTTTTTTAAATCAGCTTAGCCCAAAGGGGTTGTGAATGGGGAGGTATAAAAAGCAAAGATTATTTTTTGG CTACTAAGCCAAGAACTTACAGGGATTTTTTTTTTCAGTCCCAGAACCTACAGATACCCTGCTACTTGCTTCACGTGGATGCTCAGTGCC CAGCAGCCATCTTAATACATTAAACCAGTTTAAAAAATACCTTCCATGTGGAGAAAAACATGTCTTTTTCTCGCCTCAACTTTATCCACA TGAAATATGTGCCCATGGCTGGGCGCAGTGGCTCACCTGTAATCCCAACACTTTGGGAGGCTGAAGCAGGCAGATTGCTTGAGGCCAGGA GTTCGAGAACAGTCTGGCCAACATGGCGAAACCTCATCTCTACTAAAATTACAAAAATTAGCCGGGCATGGTGGCACATGCCTGTAATCC CAGCTACGTCAGGAGGCTGAGGCACAGGAATTGCTTGAACCCAAGAGGCAGAGGATGCAATGAGCCAAGATCACACCACTGCACTCCAGC CTTGGCGACAGAGGGAGACTCTGTCTCAAAAAAAAAAAAAAAAGGTGTGCCCAGGCCCCTAGCCATTGCCATGTGCCCAGCCAGAGAGCC AAATTAGAGGGCTGGCTTCCCTATCACACAGAATAAATGCTAGTGCTAGCCAATGATCCCTTTGCTTTTAATGTATAGAAAATACTGTTG TTCCTTTTGTCATTTCCAGTGACATCTGTTTTCTAAGCAGCTCTTTTCTAGGGAGGAAACCAAAGGGGCTAGGTTAAGACCCTAATAGAA ATGTTTTTTCTAATCTCTGGTGAGTCTGGAAGTGTCACATTCACAGTCCACCCTTGGGAGTGGCTTGGTGGAGCTGGGGACAAGGTTTTG TTTACTACATAGTGCACATGATAAATGGCCTTAAACTGTGATTCTTTCTGGTAGGATAAGTTATAATAAACTGACCCTAAAGAATGCAAT GGCTTTTAAACTGCAGTTACTGTGTTCTTAATGAAGCAATACCCAAAGCTCTGTTCTTTTGGAGCACTTGAGGGGAGCTTGAATGAAAGG TGCAGATAAGAGCAGTACCTTGATCTTATGCTTTCTGAGTGTCCTGCCTTGTTGCCATCTGCATGGATGAGTGAATGCTTCTATGCACGA GGAGACTCAAGCCAACTCAGAGTCTGCTTTTTCCAACGCTCTTCCCAGGTTTCTTTTGCAAAGCTTGGTCATTTGGCCCAGGTCTTCCTG GAAAGTGGAGTACATGTCACTGACTAGGGTGGCGTGGTGTCTTTACCCTTAACATTAAGTCTTGTTACCTCAGTGATGTGAAGCCAATGG TTGGAATTATAAAAAGCATCCTTGCTGGTTCTTCACAGGACACTGGAACCCACCCTGTCAATTCAGCTAGCATGTCCACACAGTCTTGAT GATCCCTCTCTGTAACAGGCAGCTAACATTAAGAGAAGGGGGAAAGAGAAGAAGAGAGCAATAGCTTATGGGAGAGCTGAGATCTTACTT CGTTGACCCATATTTTTCCCCTGACCAAGTTACCTGTAAACTGGAATTTGCAAGGGGATGCTGTGATGATAACCCCTTTCTATTGCTGTA ATGTTCATATAACCTGGGAAACTGAGAGAAGGGGATGTGTAAATAAAAGCTTAAACATTTTAGTAATGTGTTAAAATGTCACTCTCTCTT ACCCTGTTTCCCTTTTTTGCCAGATGATGATTTTTTTATTTTTATTTTGTACTTTACTGGATGACTGTGAAGCGATGAGTATTGGGTTGG GGTAGGTGTGTTGATTTTGAGAGTGCATGTTAAGAACTGAAGGGGAACTACTTGAGATGACTTAAGAAGCATCCCATGCAAATATCTTGT >17096_17096_2_CLEC3A-SPTLC2_CLEC3A_chr16_78056638_ENST00000575655_SPTLC2_chr14_77987924_ENST00000216484_length(amino acids)=175AA_BP=47 MAQQACPRAMAKNGLVICILVITLLLDQTTSHTSRLKARKHSKRRVRGKECVQQLAENTRYFRRRLKEMGFIIYGNEDSPVVPLMLYMPA -------------------------------------------------------------- |
Top |
Fusion Gene PPI Analysis for CLEC3A-SPTLC2 |
Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in |
Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
Hgene | Hgene's interactors | Tgene | Tgene's interactors |
- Retained PPIs in in-frame fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
- Lost PPIs in in-frame fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
- Retained PPIs, but lost function due to frame-shift fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
Related Drugs for CLEC3A-SPTLC2 |
Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.8 2021-05-08) |
Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
Related Diseases for CLEC3A-SPTLC2 |
Diseases associated with fusion partners. (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Tgene | C3150896 | NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE IC | 5 | CTD_human;GENOMICS_ENGLAND;UNIPROT | |
Tgene | C0020071 | Hereditary Sensory Autonomic Neuropathy, Type 1 | 3 | GENOMICS_ENGLAND;ORPHANET | |
Tgene | C0007959 | Charcot-Marie-Tooth Disease | 1 | GENOMICS_ENGLAND | |
Tgene | C0013364 | Dysautonomia, Familial | 1 | GENOMICS_ENGLAND |